Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 5 August 2026.
Announcements
5,266
Total raised
£159B
disclosed amounts
This month
£244M
raised so far
Earlybird led the seed round to help the London-based startup grow its product and engineering teams.
"The accounting industry has only seen one major innovation in the past decade—the move from desktop to cloud. With the rise of multimodal AI, we’re positioned to lead the coming AI revolution."
HSBC Innovation Banking UK provided the growth financing facility to support artificial intelligence development.
"Organisations require talent development in various contexts, including during change management, resilience building, and employee empowerment. CoachHub addresses these needs and more by offering a scalable, personalised, and measurable coaching solution. Our mission is to democratise coaching, unlocking the potential of every individual within an organisation."
The funding round was co-led by KHP Ventures and Cedars-Sinai Intellectual Property Co.
"This round represents a significant leap forward for 52North. With support from both UK and US healthcare leaders, we can expand our product pipeline working with major strategic partners and appropriately leverage the latest tools including AI to reshape urgent care pathways for patients worldwide. The commitment from both KHP Ventures and Cedars-Sinai exemplifies the belief in our vision and the value of our solutions."
The London-founded software comparison platform secured Seed backing from Chalfen Ventures and Seedcamp to scale its AI technology.
"The software market is at a tipping point. AI has enabled an explosion of new products, but the tools to help businesses choose the right software haven’t kept up. Stackfix is changing that with an AI-powered, real-time solution that makes software buying faster, simpler, and more accurate. We’re thrilled to have the backing of such incredible investors as we work to build the ultimate software comparison platform."
The Cambridge wound care company raised the Series C financing from existing backers to fund US market expansion and product reimbursement.
"Amadeus backed Natrox from inception and it is fulfilling to see this best-in-class technology now available in a growing number of markets. NATROX O₂ is already authorised to sell in 46 countries. It is becoming the reference advance therapy for the healing of chronic wounds across private and public health systems globally. Securing national coverage in the US is another step forward for the team."
